New drug joins fight against deadly brain tumors
Disease control
Terminated
This early-stage study is testing whether adding an experimental drug called S-Gboxin to standard brain cancer treatment helps control aggressive tumors like glioblastoma. It will involve about 10 patients with these difficult-to-treat cancers. Researchers will monitor how patien…
Phase: PHASE1 • Sponsor: Petrov, Andrey • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC